News Focus
News Focus
Followers 23
Posts 1098
Boards Moderated 0
Alias Born 02/09/2001

Re: DewDiligence post# 55747

Friday, 08/27/2010 12:48:37 PM

Friday, August 27, 2010 12:48:37 PM

Post# of 347009
Hmmm, so which biotech companies that you follow consider FoBs germane to their business? How many of their drugs will be vulnerable to Biosimilars in the next few years?

As an example, in your area I am thinking Genzyme and its niche drugs which BP may consider too small a market for their mega manufacturing capabilities to bother with.